58 Days
Source:
جفرا نيوز
جفرا نيوز
Ready to play
Ready to play
The Jordan Food and Drug Administration announced the registration of the first locally manufactured pneumococcal vaccine, produced in partnership with the Chinese company Walvax for Taajeer Pharmaceuticals. The TQ-PCV VAX 13-valent Pneumococcal Polysaccharide Conjugate Vaccine aims to protect children aged three months to five years from infectious diseases caused by 13 strains of Streptococcus pneumoniae bacteria. This achievement enhances the capabilities of the national pharmaceutical industry and reaffirms Jordan's position as a regional hub for pharmaceutical industries and innovation in the healthcare sector.
Notice: This Is an AI-Generated Summary
Comments (0)